Confidential & Proprietary :: Aleafia Health Inc.
Investor Presentation
TSX: ALEF | OTC: ALEAF | FRA: ARAH December 2018
Investor Presentation TSX: ALEF | OTC: ALEAF | FRA: ARAH December - - PowerPoint PPT Presentation
HEALTH Investor Presentation TSX: ALEF | OTC: ALEAF | FRA: ARAH December 2018 Confidential & Proprietary :: Aleafia Health Inc. HEALTH VISION :: Driven by our distinguished leadership team, Aleafia Health is moving forward as the premier
Confidential & Proprietary :: Aleafia Health Inc.
TSX: ALEF | OTC: ALEAF | FRA: ARAH December 2018
Aleafia Health Inc. :: Confidential & Proprietary
2
HEALTH
VISION :: Driven by our distinguished leadership team, Aleafia Health is moving forward as the premier enterprise engaging in cutting-edge innovation, research, and development that will strengthen the science of medical cannabis. MISSION :: Aleafia Health is committed to being Canada’s leading patient-focused healthcare enterprise offering medical cannabis care. Through education, research, and development, we will advance the cultivation and science of medically authorized cannabis.
Aleafia Health Inc. :: Confidential & Proprietary
3
HEALTH
LEGAL DISCLAIMER Cautionary statements regarding forward-looking information
Certain statements herein relating to the Company constitute “forward looking statements”, within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and/or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are “forward-looking statements”. Such “forward-looking statements involve unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including production and/or sales of medical marijuana, quantities of future medical marijuana production, anticipated revenues in connection with such sales., the overall projected size of the market, completion and/or expansion of production facilities, and other Information that is based on forecasts of future results, estimates of production not yet determinable, and other key management assumptions. Actual results may differ materially from those expressed or implied by such forward-looking statements and involve risk and uncertainties relating to the Company’s historical experience with regulatory changes, timeliness of government approvals for the granting
circumstances unless required by law. Contents are provided for general information purposes only and do not constitute an
Aleafia Health Inc. :: Confidential & Proprietary
4
HEALTH
1) Profitability in Q3 at both Farms (Sub-5% of Funded Grow Capacity) and Clinics (Pre-Launch of Product Offerings to Our Own Consumers). Poised for Exponential Growth at 98 Million Grams Annual Run Rate by end of 2019. 2) Product Cultivation Leadership in Quality, Costs, Weight, Efficiency, and Standardization Creating Predictable and High Demand Cannabis 3) 2nd Mover Advantage in High Capital Cost Production, Processing and Storage Driven Investments Based on Regulatory Body Dynamic Environment and Industry Best Practices 4) Consumer Acquisition Channel Ready to Scale to Life-Time Value Model with Subscription Health & Wellness Services and Delivered to Home Products 5) Partnership Acceleration – Product to Market via Product Processing/Extraction, and Packaging, as well as Retail Storefront via SPE Investment, Brand Joint-Venture 6) International Launch with Health & Wellness Lead Opportunity. Phase 1 = Execute Australia to Open Up Asia-PAC, and then Enter South America & European Union 7) The Team to Exponentially Grow and Scale Profitability
Margin Visibility is Proven & Clear. Time to Accelerate Canada and Scale to International
Aleafia Health Inc. :: Confidential & Proprietary
5
HEALTH
H e a l t h & We l l n e s s D o m i n a t e o v e r N ex t 5 Ye a r s
Legal Marijuana Market Worth US $146.4 Billion by 2025
2025 Market Size (US Billions $)
Medical Non-Medical
Capitalize on Medical First Legalization Experience and Market Leadership to Scale Internationally
Aleafia Health Inc. :: Confidential & Proprietary
6
HEALTH
Ticker Symbol (close of day Friday, November 23rd, 2018) TSXV: ALEF RECENT SHARE PRICE $2.14 SHARES ISSUED AND OUTSTANDING (basic / diluted) 157 Million / 180 Million MARKET CAPITALIZATION (basic / diluted) $335 Million / $385 Million CURRENT PATIENT COUNT +50,000 CLINIC FACILITIES 22 clinics across Canada PRODUCTION FACILITIES 2 - Port Perry & Niagara CURRENT PRODUCTION CAPACITY ~1 Million Grams 2019 PRODUCTION CAPACITY (indoor, greenhouse & outdoor) 98 Million Grams TOTAL CASH POSITION $27.8 Million CASH PROCEEDS (from all options / warrants) $25.1 Million POTENTIAL CASH (including option / warrant exercise) $52.9 Million
Aleafia Health Inc. :: Confidential & Proprietary
7
HEALTH
Parent Company with 4 Key Operating Units
Cannabis Product Production
(Aleafia Farms)
Health & Wellness Services
(Canabo Clinics)
Education Services
(New Brand In-Process)
Cannabis Consumer Experience
(New Brands In-Process + Product Brands) R&D > Seed > Science > Labs > Farm > Grow > Quality Process > Extract > Formulate > Format > Dosages Doctors Education, Diagnosing, Treating and Patient Dosing Referring Doctors Recruitment, Education & Diagnosing Training Educators & Practitioners Patients & Families Leading Engagement Platform with White Label & Customizations Unique IP Content & Data :: Courses, Lessons, Modules Corporate, Government, Insurers, Benefits, Unions Associations Licenses & Certifications eCommerce Marketplace (Medical & Recreational) Retail Storefront Joint Venture Medical & Non-Medical Cannabis Brands (Direct & Partner) Recreational Cannabis Brand x 3 Wholesale Raw Cannabis Sales to Canadian LPs and Exports Packaging > Shipping > Subscription > Scheduled Home Delivery
At-a-Glance, Quantifications and Key Differentiators
Aleafia Health Inc. :: Confidential & Proprietary
8
HEALTH
Cannabis Product Production
(Aleafia Farms)
Health & Wellness Services
(Canabo Clinics)
Education Services
(New Brand In-Process)
Cannabis Consumer Experience
(New Brands In-Process + Product Brands) Port Perry > 1 Million Grams of Indoor (Selling) + Secured Approval for 60 Million Grams of Outdoor (Q2) Niagara > 37 Million Grams of Indoor Perpetual Harvest (Q1) 10 Million Patient Data Points from 50,000+ Patients & Growing 4+ Years of Experience Today > 22 Canadian Clinics with 100+ Doctors and Practitioners Deep Medical Patient On-Boarding & Diagnosing IP & Processes Leader in Clinic Studies & Strongly Positioned as the Opioid Killer Courseware :: Cannabis 101, Workplace, Referring Doctors, Doctors, Patients/Families Software-as-a-Service :: Multi- Language, Interactive, Gamification Expandable, Customization for Companies & Governments Global Spearhead to Enter & Educate New Countries, Doctors & Patients Canadian & Global eCommerce Marketplace for Cannabis & Lifestyle Products & Services Canadian JV Retail Storefront & US Leading Brands to Canada + International Consumer (Patient + Rec. Customer) Consolidated Database & Premium Experience Supports 3rd Party Clinic Patient Registrations, Orders and LPs Global Repeatable Production Blueprint & Execution Annual Run Rate Capacity of 98 Million Grams in 2019 (15 Million Agreement to CannTrust)
Acceleration Partners
Aleafia Health Inc. :: Confidential & Proprietary
9
HEALTH
LEA M RAY
VERBORA WILLIAM STEWART MARK J SANDLER GARY GOODYEAR RAF SOUCCAR
JULIAN FANTINO
Chairman
’00) and London (‘91-’98), Ontario’s Commissioner of Emergency Mang. (‘05-’06)
’10), Minister of Veterans Affairs (‘13-’15)
Global Leading & Unparalleled Law Enforcement, Regulatory, Government, Legal, Accounting and Cannabis Experience
Commissioner of Federal and International Policing (34 years)
appointed Member, Task Force on Marijuana Legalization & Regulation
Service as Chief of Toronto Fire Services (40 years of service)
Officer of the Canadian Armed Forces
Professional Accountant (CPA)
Governance Committees and Board Vice-Chair
Finance, of Warner
Canada Inc. (19 years)
Chiropractic, Member of Parliament
Science and Technology, Minister
Federal Economic Development Agency
Veterans Affairs (‘13- ’15)
Shime & Bergman LLP,
Foundation, Ontario, Adjunct Professor, Osgoode Hall Law School
Doctor, Completed 10,000+ cannabinoid therapy consultation
McMaster University School of Medicine
Aleafia Health Inc. :: Confidential & Proprietary
10
HEALTH
1) Geoff Benic, CEO 2) Benjamin Ferdinand, CFO 3) Greg Rossi, COO 4) Trevor Newell, CMTO 5) Lucas Escott, SVP Production 6) Gary Goodyear, President Clinic Operations 7) Nicholas Bergamini, VP Public Affairs
Proven Exponential Global Growth Strategy, Execution and Shareholder Value Creation
Aleafia Health Inc. :: Confidential & Proprietary
11
HEALTH
S i g n i f i c a n t d i s c o u n t t o p e e r g r o u p ; m u l t i p l e e s c a l a t i o n u p o n e x e c u t i o n
Enterprise Value / 2020 E EBITDA
Aleafia Health Inc. :: Confidential & Proprietary
12
HEALTH
Aleafia Health Inc. :: Confidential & Proprietary
13
HEALTH
Aleafia Inception
2016
3 Rounds of Financing
Friends & Family
MAR
TSX Listing
TSX Venture listing as AELF.TSXV
MAR
Niagara Facility
Announce acquisition of Niagara Greenhouse
MAY
1st Harvest
Pre-Sold to CannTrust
MAY
Port Perry
Secure Health Canada bulk sales license
SEP
2nd Harvest
Sold to Licensed Producer
SEP
Medical Study
Sleep Study w Cronos
SEP
NASDAQ Listing
Application Submitted
OCT
Merger
Aleafia & Canabo merge 22 clinics, 40k patients
JAN
Port Perry Grow
Partner with CannTrust
JUN
Niagara Facility
Close on 160,000 sq. ft Automated Greenhouse
JUL
Facility Expansion
Adding 60 million grams grow capacity in Secure Outdoor Expansion
OCT
Clinic Expansion
Expansion of Telemedicine
OCT
Port Perry
Acquired cultivation facility
DEC
2016
Port Perry
Secure Health Canada ACMPR License to Produce
DEC
2018
1st Cannabis Sale
Sold to CannTrust
SEP
Warrant Trigger
Performance based
SEP
2019
Retail JV w Serruya
Proven Brands, + $10M Private Equity Investment
NOV
1st Global Expansion
Australia (CannaPacfic 10%)
NOV
Medical Study
Pharmacogenetics Study w G420 & AKESOgen
NOV
Global Education
D2L Platform + Medical IP
NOV
Profitability (Farms, Clinics)
Q3 Earnings
NOV
Future Direction
Prescription Orders
NEW
2017